What is the appropriate management of hyperkalemia and bowel ileus in a one‑month‑old infant?

Management of Hyperkalemia and Bowel Ileus in a One-Month-Old Infant

In a one-month-old infant presenting with hyperkalemia and bowel ileus, immediately stabilize cardiac conduction with IV calcium (20 mg/kg calcium chloride over 30-60 minutes), shift potassium intracellularly with glucose (200 mg/kg as D10W) plus insulin (0.1 unit/kg with 400 mg/kg glucose), and avoid sodium polystyrene sulfonate due to the high risk of gastrointestinal complications including intestinal obstruction and necrosis in this age group with pre-existing bowel pathology. 1

Immediate Cardiac Stabilization

The first priority is protecting the myocardium from life-threatening arrhythmias:

• Calcium chloride 20 mg/kg (0.2 mL/kg of 10% solution) IV/IO over 30-60 minutes while monitoring heart rate 1
• Calcium chloride is preferred over calcium gluconate in critically ill children as it produces a more rapid increase in ionized calcium
• Stop injection if symptomatic bradycardia occurs
• Central venous access is preferred; peripheral extravasation causes severe tissue injury

Intracellular Potassium Shift

After cardiac stabilization, shift potassium into cells:

• Glucose 200 mg/kg as D10W IV (2 mL/kg of D10W) 1
• Insulin 0.1 unit/kg with 400 mg/kg glucose (ratio: 1 unit insulin per 4 g glucose) 1
• Monitor glucose and potassium hourly or more frequently
• The guideline notes that glucose alone is effective for hyperkalemia in pediatrics 1

Critical Contraindication: Avoid Potassium Binders

Do not use sodium polystyrene sulfonate (SPS) or other potassium binders in this clinical scenario. The combination of bowel ileus in a neonate creates an extremely high-risk situation:

• SPS has been associated with intestinal ischemia, colonic necrosis, and inspissated material causing complete intestinal obstruction 2, 3
• A case report documented acute intestinal obstruction from inspissated Kalimate (calcium polystyrene sulfonate) requiring exploratory laparotomy 3
• The onset of action is variable (hours to days) and efficacy is inconsistent 2
• In a pediatric study, 43% of patients required additional interventions after SPS, and 15% experienced gastrointestinal adverse events 4
• The pre-existing bowel ileus makes mechanical obstruction from inspissated resin material a near-certainty

Identify and Address Underlying Causes

In a one-month-old with hyperkalemia and ileus, immediately investigate:

• Congenital adrenal insufficiency (CAH): This is a critical diagnosis in neonates presenting with hyperkalemia, vomiting, and electrolyte disturbances 5

  • Check serum cortisol, 17-hydroxyprogesterone, aldosterone, and renin
  • If suspected, give hydrocortisone 2-3 mg/kg IV over 3-5 minutes, followed by 1-5 mg/kg every 6 hours 1
  • Administer fluid bolus 20 mL/kg of D5NS or D10NS during first hour 1

• Intestinal integrity disruption: Ileostomy or bowel pathology can cause persistent hyperkalemia in extremely low birth weight infants 6

• Renal function: Assess for acute kidney injury

• Pseudohyperkalemia: Hemolysis from difficult blood draw in neonates is common 7

Monitoring Requirements

• Continuous cardiac monitoring with ECG
• Serum potassium every 1-2 hours initially
• Blood glucose monitoring hourly
• Sodium, calcium, and magnesium levels
• Watch for ECG changes: tall peaked T waves → widened QRS → prolonged PR interval → arrhythmias 5

Definitive Potassium Removal

If hyperkalemia persists despite initial measures:

• Diuretics (if renal function adequate and patient euvolemic/hypervolemic)
• Dialysis may be necessary for severe, refractory hyperkalemia, especially if renal failure is present
• The newer oral potassium binders (patiromer, sodium zirconium cyclosilicate) are not FDA-approved for pediatric use and have no safety data in neonates 2, 8

Common Pitfalls to Avoid

• Never use SPS in a patient with bowel ileus - the risk of complete obstruction and bowel necrosis is unacceptably high
• Do not underdose hydrocortisone if adrenal insufficiency is suspected 1
• Avoid D50W in neonates - it is highly irritating to veins; use D10W instead 1
• Do not delay calcium administration while waiting for other interventions - cardiac protection is the immediate priority
• Remember that insulin will cause hypoglycemia if glucose is inadequate; maintain the 1:4 ratio

The bowel ileus in this case fundamentally changes the management approach by eliminating gastrointestinal potassium removal as a safe option, making cardiac stabilization, intracellular shift, and identification of the underlying cause (likely adrenal insufficiency) the cornerstones of management.